Wearable Single-Lead Electrocardiogram Patch for detection of atrial fibrillation after an embolic stroke of undetermined origin: a multicenter randomized controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0007505

Enrollment

400

Registered

2022-07-18

Start date

2022-08-01

Completion date

Unknown

Last updated

2022-09-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : Patients with embolic stroke of unknown etiology included in the study will be randomly assigned to participants in a 1:1:1 ratio before discharge to a mobiCARE monitor group (interve

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: A. Adult patients aged 55 years or older who were hospitalized for ischemic stroke from November 1, 2021 to December 31, 2024 B. Patients who visited the hospital within 7 days after symptom onset (First abnormal time) C. Patients with embolic stroke (ESUS) of unknown cause for ischemic stroke (Trial of ORG 10172 in Acute Stroke Treatment) classification

Exclusion criteria

Exclusion criteria: A. Patients wearing less than 50% of wearable devices during the study period B. Patients who are unable to understand or adhere to the study protocol or who lack the ability to express themselves C. Patients who have difficulty in ECG patching due to skin reactions or allergies

Design outcomes

Primary

Measure	Time frame
Diagnosis of Atrial Fibrillation	—

Secondary

Measure	Time frame
Prescription of Anticoagulants	—

Countries

Korea, Republic of

Contacts

Public ContactMinwoo Lee

Hallym University

minwoo.lee.md@gmail.com+82-31-380-3740

Outcome results